Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist | RemedyX Labs Research Library

A research summary of Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist, covering Retatrutide (RXL-3RT) in the context of systematic review / meta-analysis research. Cited source and RUO context from RemedyX Labs.